Icon PLC (ICLR): Cash & Equivalents
$647.29M
As of 2025-12-31
+30.9%
3-year compound annual growth
-5.1%
5-year compound annual growth
+20.1%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $647.29M | +20.1% | 2026-05-27, Balance as of period end |
| 2024-12-31 | $538.78M | +42.5% | 2026-05-27, Balance as of period end |
| 2023-12-31 | $378.10M | +30.9% | 2026-05-27, Balance as of period end |
| 2022-12-31 | $288.77M | -61.6% | 2024-02-23, Balance as of period end |
| 2021-12-31 | $752.21M | -10.5% | 2023-02-24, Balance as of period end |
| 2020-12-31 | $840.30M | +61.5% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $520.31M | +31.4% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $395.85M | +39.9% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $282.86M | +46.9% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $192.54M | +85.3% | 2019-03-01, Balance as of period end |
| 2015-12-31 | $103.91M | -12.6% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $118.90M | -34.9% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $182.52M | +60.0% | 2016-03-23, Balance as of period end |
| 2012-12-31 | $114.05M | -4.4% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $119.24M | -53.4% | 2014-03-12, Balance as of period end |
| 2010-12-31 | $255.71M | +76.6% | 2013-03-06, Balance as of period end |
| 2009-12-31 | $144.80M | +148.0% | 2012-03-02, Balance as of period end |
| 2008-12-31 | $58.38M | n/a | 2011-03-22, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Icon PLC (ICLR) | 2025-12-31 | $647.29M | +20.1% |
| Incyte Corp (INCY) | 2025-12-31 | $3.10B | +83.5% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $1.98B | +16.3% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $213.77M | +9.8% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $497.05M | -25.8% |
| NRC Health (NRC) | 2025-12-31 | $4.14M | -2.2% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $20.07M | -28.0% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $25.52M | -7.5% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $207.5K | +203.9% |
Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗